MIRUS LLC

Mirus LLC specializes in spinal fixation devices. Their primary products include non-bioabsorbable pedicle screws for spinal stabilization, metallic interbody fusion cages, and internal fixation rod systems designed for minimally invasive spinal procedures. These devices are engineered to support surgical interventions for spinal alignment and structural integrity.

Mirus LLC is headquartered in the United States. The company’s location is relevant for regulatory oversight, as its devices are subject to FDA requirements and classifications applicable to US-based manufacturers.

Mirus LLC’s devices are classified as Class II medical devices under FDA regulations. This classification applies to products that pose moderate risk and require special controls to ensure safety and effectiveness, such as spinal fixation hardware. Class II devices typically require premarket notification (510(k)) clearance or other regulatory pathways to demonstrate compliance with FDA standards.

Mirus LLC’s devices are listed in the FDA’s regulatory databases, specifically through 510(k) clearances and the FDA’s Unique Device Identification (UDI) system. These registries ensure transparency and traceability of authorised medical devices, allowing healthcare providers, regulators, and patients to access critical information about the devices’ safety, performance, and compliance status.

The FDA’s Unique Device Identification (UDI) system assigns a unique product code to each device to improve tracking, reduce medical errors, and enhance post-market surveillance. Mirus LLC’s devices are authorised through UDI to ensure accurate identification in clinical settings, regulatory reporting, and public health monitoring, which helps maintain patient safety and device accountability throughout their lifecycle.